FR2413910A1 - Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine - Google Patents

Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine

Info

Publication number
FR2413910A1
FR2413910A1 FR7835419A FR7835419A FR2413910A1 FR 2413910 A1 FR2413910 A1 FR 2413910A1 FR 7835419 A FR7835419 A FR 7835419A FR 7835419 A FR7835419 A FR 7835419A FR 2413910 A1 FR2413910 A1 FR 2413910A1
Authority
FR
France
Prior art keywords
cancer
chlorobenzyl
tetrahydrothieno
pyridine
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835419A
Other languages
English (en)
Other versions
FR2413910B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sopharma SA
Original Assignee
Sopharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sopharma SA filed Critical Sopharma SA
Publication of FR2413910A1 publication Critical patent/FR2413910A1/fr
Application granted granted Critical
Publication of FR2413910B1 publication Critical patent/FR2413910B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'INVENTION A POUR OBJET UN MEDICAMENT ANTICANCEREUX ET DE PREVENTION DES METASTASES CANCEREUSES CARACTERISE EN CE QU'IL CONTIENT, COMME PRINCIPE ACTIF, DE LA 5-(2-CHLOROBENZYL)-4,5,6,7-TETRAHYDROTHIENO3,2-CPYRIDINE OU UN SEL D'ADDITION AVEC UN ACIDE THERAPEUTIQUEMENT ACCEPTABLE DE CELLE-CI. LE SEL THERAPEUTIQUEMENT ACCEPTABLE EST NOTAMMENT LE CHLORHYDRATE APPELE TICLOPIDINE.
FR7835419A 1978-01-06 1978-12-15 Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine Granted FR2413910A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46578A JPS5498337A (en) 1978-01-06 1978-01-06 Anticarcinogenic and/or antimetastatic agent

Publications (2)

Publication Number Publication Date
FR2413910A1 true FR2413910A1 (fr) 1979-08-03
FR2413910B1 FR2413910B1 (fr) 1980-10-24

Family

ID=11474538

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835419A Granted FR2413910A1 (fr) 1978-01-06 1978-12-15 Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine

Country Status (9)

Country Link
US (1) US4963559A (fr)
JP (1) JPS5498337A (fr)
AU (1) AU519516B2 (fr)
BE (1) BE873326A (fr)
DE (1) DE2900203A1 (fr)
FR (1) FR2413910A1 (fr)
GB (1) GB2012161A (fr)
IT (1) IT1117201B (fr)
ZA (1) ZA787217B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612777A1 (fr) * 1987-03-26 1988-09-30 Inst Nat Sante Rech Med Composition medicamenteuse pour le traitement et la prevention de maladies dues a une cytotoxicite a mediation cellulaire, renfermant au moins un derive de la pyridine comme principe actif
US5562277A (en) * 1994-09-02 1996-10-08 Chick Machine Tool, Inc. Modular vise-like workholding system
WO1996026675A1 (fr) * 1995-02-28 1996-09-06 Boston Scientific Corporation Catheter a deflexion pour l'ablation d'un tissu cardiaque
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
US7723523B2 (en) * 2004-05-28 2010-05-25 4Sc Ag Tetrahydropyridothiophenes
ATE397000T1 (de) * 2004-06-04 2008-06-15 Nycomed Gmbh Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
AU2005251485A1 (en) * 2004-06-11 2005-12-22 4Sc Ag Tetrahydropyridothiophenes for treating hyperproliferative disorders
AU2006212224A1 (en) 2005-02-09 2006-08-17 4Sc Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
EP1851230A1 (fr) * 2005-02-11 2007-11-07 Nycomed GmbH Tetrahydropyridothiophenes en tant qu'agents antiproliferatifs pour le traitement du cancer
US20090252706A1 (en) * 2005-02-11 2009-10-08 Klaus Pekari Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
EP1893618A2 (fr) * 2005-05-25 2008-03-05 Nycomed GmbH Tetrahydropyridothiophenes utilisés dans le traitement anticancereux
EP1896484A2 (fr) * 2005-05-25 2008-03-12 Nycomed GmbH Tetrahydropyridothiophenes utilisés dans le traitement anticancereux
WO2014087240A2 (fr) * 2012-12-04 2014-06-12 Dalhousie University Compositions, procédés et coffrets de prévention, de réduction et d'élimination de métastase de cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948A1 (fr) * 1973-02-01 1974-08-30 Centre Etd Ind Pharma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948A1 (fr) * 1973-02-01 1974-08-30 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
US4963559A (en) 1990-10-16
AU519516B2 (en) 1981-12-10
IT7947524A0 (it) 1979-01-04
JPS6153325B2 (fr) 1986-11-17
GB2012161A (en) 1979-07-25
IT1117201B (it) 1986-02-17
AU4316879A (en) 1979-07-12
FR2413910B1 (fr) 1980-10-24
BE873326A (fr) 1979-07-05
DE2900203A1 (de) 1979-07-12
JPS5498337A (en) 1979-08-03
ZA787217B (en) 1979-12-27

Similar Documents

Publication Publication Date Title
FR2413910A1 (fr) Medicament anti-cancereux et preventif des metastases cancereuses a base de 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
DZ2103A1 (fr) (Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2.
FR2435248A1 (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ATE82968T1 (de) Hemmung vom 5-lipoxygenase-weg.
SE8402550L (sv) N-substituerade deridvat av moranolin
FR2378523A1 (fr) Medicament pour le traitement de l'acne
SE8204581L (sv) Farmaceutiska excipienter
IT1257474B (it) Impiego di inibitori di aromatosi per contraccezione in primati femmine senza influire sul ciclo mestruale
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
GB1533358A (en) Deamino derivatives of the kallikrein-trypsin inhibitor processes for their preparation and their use as medicament
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
FR2392991A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
FR2386566A1 (fr) Copolymere a base de methacrylate de methyle approprie pour le revetement de produits alimentaires ou medicaments
FR2358159A1 (fr) Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
FR2417503A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
FR2377804A1 (fr) Compositions analgesiques et anti-inflammatoires comprenant des derives de chromone
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property